Skip to main content

For the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Request a Rep Referral Form
Skip to main content
Referral Form

PREVALENCE

PH may be present at any stage of ILD, even at diagnosis2-4

up to fifteen

Up to 15% of patients with early-stage IPF have confirmed PH.2-4

fifty percent

As ILD advances, PH frequency rises.2

In patients with advanced and end-stage IPF, PH prevalence can rise beyond 50%2*

up to eighty-six

Up to 86% of patients with IPF may develop PH by the time of lung transplant.5

Check for PH at diagnosis of ILD, when you review your patient's CT, and during routine follow-ups.3,6-8

*Composite graphical representation of the mPAP distribution observed across multiple studies in patients with IPF.

ILD=interstitial lung disease; IPF=idiopathic pulmonary fibrosis; mPAP=mean pulmonary arterial pressure; PH=pulmonary hypertension.